Atlas Trials

Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19

Clinical trial NCT04876573 · UNKNOWN

Trial details

NCT number
NCT04876573
Sponsor
Ciusss de L'Est de l'Île de Montréal
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Viral PneumoniaCOVID-19 PneumoniaSerotonin SyndromePlatelet Dysfunction
Start date
2021-06-01
Primary completion
2021-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.